Researchers Identify Vulnerability in p53 Protein, Offering New Cancer Treatment Insights
A study led by researchers from the Federal University of Rio de Janeiro and other institutions has uncovered why the p53 protein, known as the 'guardian of the genome', is prone to collapse and mutation, making it a frequent contributor to cancer. The research, published in Communication Chemistry, reveals that p53's sequence is inherently fragile due to 'energetic frustration', which prevents it from maintaining a stable structure. This fragility, while allowing p53 to perform various cellular roles, also makes it susceptible to forming harmful aggregates. The study suggests that this vulnerability is an evolutionary trade-off for functional flexibility, unlike its more stable paralogs, p63 and p73. 
